BioSpace News Archive

Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform, announced it will report financial results for the third quarter before market open on Tuesday, October 31, 2023.

Tempest Therapeutics, Inc. announced that its Board of Directors has adopted a limited duration stockholder rights plan, effective immediately.

Daxor Corporation, the global leader in blood volume measurement technology, announces new data from Banner University Medicine Advanced Heart Failure Clinic in Phoenix, AZ validating the benefits of the Company’s BVA-100 diagnostic blood test for ambulatory patients with advanced heart failure.

Shionogi & Co., Ltd. announced that it will present real-world evidence suggesting treatment with Fetroja® is effective in treating Gram-negative infections and that appropriate patients who received Fetroja earlier had lower in-hospital all-cause mortality than those receiving it later.1 The data are being presented at IDWeek 2023, which is taking place in Boston, October 11-15.

Forge Biologics (Forge), a leading manufacturer of genetic medicines, announced today that it has joined the California Institute for Regenerative Medicine’s (CIRM) Industry Resource Partner Program to help advance the manufacturing of adeno-associated adenovirus (AAV) gene therapy programs from the state of California.

Innoviva Specialty Therapeutics Presents New Data on its Critical Care Antibiotic Therapy Portfolio at Infectious Disease Week (IDWeek) 2023.

Incyte (Nasdaq:INCY) today announced new 52-week data from a Phase 2b clinical trial evaluating the safety and efficacy of povorcitinib (INCB54707), an investigational oral JAK1 inhibitor, in adult patients with extensive nonsegmental vitiligo.

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that, while working toward previously announced environmental goals, the Company has achieved 90 percent renewable electricity globally.

AN2 Therapeutics, Inc. announced two oral presentations and three poster presentations at the Infectious Disease Society of America IDWeek 2023 Conference from October 11-15, 2023 in Boston, Massachusetts.

Smith+Nephew, the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine, is pleased to announce the opening of the purpose-built Smith+Nephew Academy Munich, a new centre for surgical innovation and training.